PCN101 COST-EFFECTIVENESS ANALYSIS OF TORIPALIMAB VERSUS PEMBROLIZUMAB FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC MELANOMA IN CHINA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.298
https://www.valueinhealthjournal.com/article/S1098-3015(19)32676-2/fulltext
Title :
PCN101 COST-EFFECTIVENESS ANALYSIS OF TORIPALIMAB VERSUS PEMBROLIZUMAB FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC MELANOMA IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32676-2&doi=10.1016/j.jval.2019.09.298
First page :
Section Title :
Open access? :
No
Section Order :
10238